Sodium Deoxycholate Formulation pH Stabilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Aqueous solutions of sodium deoxycholate at low concentrations are prone to precipitation, limiting their shelf life and requiring frequent dilution before use, which is not ideal for routine administration in fat removal treatments.

Innovation Solution

Maintaining the pH of sodium deoxycholate solutions between 8.0 and 8.5 inhibits precipitation, stabilizing the formulation and extending its shelf life, allowing for effective and safe fat removal without the need for frequent dilution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If aqueous solutions of sodium deoxycholate are prepared at low concentrations, then the formulation is more dilute and easier to administer, but precipitation occurs rapidly limiting shelf life

Engineering Contradiction:
Improveconcentration of sodium deoxycholateVSAvoidshelf life of formulation
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by adjusting the pH of the aqueous solution to a specific range (pH 8.0-8.5) to prevent precipitation of sodium deoxycholate. This chemical parameter modification allows low concentration formulations to remain stable over extended periods, resolving the contradiction between dilution and shelf life.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If aqueous solutions of sodium deoxycholate are prepared at low concentrations, then the formulation requires less dilution before use, but precipitation occurs limiting storage stability

Engineering Contradiction:
Improveease of administrationVSAvoidstorage stability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

By changing the pH parameter to the optimal range of 8.0-8.5, the formulation achieves both ease of administration (low concentration) and storage stability (no precipitation). This parameter optimization allows the solution to remain stable during storage while requiring minimal or no dilution before use.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If the pH of sodium deoxycholate solution is maintained at 8.0 to 8.5, then precipitation is inhibited and shelf life is extended, but the formulation requires precise pH control

Engineering Contradiction:
Improveshelf life of formulationVSAvoidpH control requirement
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent identifies pH 8.0-8.5 as the optimal range that prevents precipitation while maintaining formulation stability. By targeting this specific parameter range, the invention achieves extended shelf life without requiring overly complex control systems, as the pH range provides a buffer zone for stability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The stabilization of sodium deoxycholate solutions at pH 8.0 to 8.5 prevents precipitation for extended periods, enhancing storage stability and maintaining the active ingredient's concentration, thus improving the efficacy and safety of fat removal treatments.

Implementation Method 1

aqueous solutions of sodium deoxycholate at low concentrations are prone to precipitation... Maintaining the pH of sodium deoxycholate solutions between 8.0 and 8.5 inhibits precipitation

Methodology Applied
Scientific EffectPrecipitation inhibition through pH control: Precipitation

Data Source

PatentUS10500214B2Formulations of deoxycholic acid and salts thereof
Publication Date: 2019.12.10 ALLERGAN SALES LLC
  • US10500214B2 patent drawing
  • US10500214B2 patent drawing
  • US10500214B2 patent drawing

AI summary

The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.